IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...

SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...

Certain serious fungal infections occur in regions of the United States with specific environments and are often tied to soil exposure. These infections can affect both healthy and immunocompromised ...

The U.S. Bloodstream Infection Testing Market is projected to grow from USD 221.68 Million in 2025 to USD 355.49 Million by ...

The U.S. Laboratory Developed Tests Market is projected to grow from USD 5.97 Billion in 2025 to USD 11.85 Billion by 2035, while Europe is expected to expand from USD 3.75 Billion to USD 7.55 Billion ...

Earnings Call Insights: Insight Molecular Diagnostics Inc. (IMDX) Q3 2025 CEO Joshua Riggs highlighted that Insight Molecular Diagnostics is nearing a transformative milestone, stating, "In 2026, with ...

Please provide your email address to receive an email when new articles are posted on . Precision medicine has shown great potential to improve treatment outcomes and prolong survival of patients with ...

Before testing new therapies in animals, researchers now have a more efficient starting point—lab-grown canine muscle cells that can help identify what works and what doesn't.